Hours

Minutes

Seconds

-40%

on all subscriptions*

Last days

Enjoy this offer

* See conditions under "Our services"

Ortivus AB is a Sweden-based provider of mobile solutions for modern emergency medical services. The Company is engaged in the development of mobile surveillance and communication solutions, forming a decision support system. Its offering comprises: MobiMed Smart, a decision support system, which allows ambulance personnel to handle documentation, monitoring and introduce a structured approach in prehospital care; CoroNet, a mobile surveillance solution which allows patients to move freely under supervision of medical staff and provides healthcare professionals with monitoring information. In addition, the Company provides a wide range of services, such as support, implementation, training and consulting, among others. The Companyâ€™s customer base includes mainly ambulance services and emergency departments.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

08-25 - Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
12/06/26	1.800 kr	0.00%	225
11/06/26	1.800 kr	-2.96%	332
10/06/26	1.855 kr	-1.33%	2,500
09/06/26	1.880 kr	+3.87%	10,805
08/06/26	1.810 kr	+2.84%	10,666

Delayed Quote Nasdaq Stockholm

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Nasdaq Stockholm Other stock markets 20:00:00 12/06/2026 +04			5-day change	1st Jan Change
1.800 ^SEK	0.00%		+2.27%	+48.15%

05-07	Ortivus AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-04	Ortivus Exits H&E Solutions Shareholding	MT

Market Cap	160M 16.99M 14.69M 13.55M 12.69M 23.8M 1.62B 24.16M 62.31M 787M 63.77M 62.42M 2.75B	P/E Ratio 2024	-2.47x	P/E Ratio 2025	-2.86x
Enterprise Value	171M 18.12M 15.67M 14.44M 13.53M 25.38M 1.72B 25.76M 66.45M 839M 68M 66.56M 2.93B	EV / Sales 2024	1.19x	EV / Sales 2025	1.61x
Free-Float	83.17%	Yield 2024 *	-	Yield 2025	-

05-07	Ortivus AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-04	Ortivus Exits H&E Solutions Shareholding	MT
05-04	Ortivus completes sale of its holding in H&E Solutions	RE
04-21	Ortivus AB Appoints Matti Zemack as New Chief Product Officer	CI
02-19	Ortivus AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
02-04	19 Stocks Reach New 52-Week Highs on the Stockholm Stock Exchange So Far Today	FW
01-13	Ponderus Invest has announced final outcome of cash offer to shareholders of Ortivus	RE
01-12	Ponderus Invest AB completed the acquisition of remaining 39.42% stake in Ortivus AB (OM:ORTI B).	CI
12-22	Ponderus announces approval regarding cash offer to shareholders of Ortivus	RE
12-18	Ortivus: Independent bid committee unanimously recommends to not accept mandatory cash offer	RE
12-17	Ortivus: Appointment of Minni Raij as CFO	RE
12-17	Ortivus AB Appoints Minni Raij As Chief Financial Officer, Effective February 16, 2026	CI
12-02	Ponderus Invest AB proposed to acquire remaining 39.42% stake in Ortivus AB (OM:ORTI B) for approximately SEK 42.6 million.	CI

05-27	PRESS RELEASE	AQ
05-07	Interim Report for Ortivus AB (publ) for the period January-March 2026	AQ
05-04	Ortivus AB completes sale of its holding in H&E Solutions AB and realises a profit	AQ
04-21	Ortivus AB welcomes Matti Zemack as new Chief Product Officer	AQ
03-31	Ortivus AB publishes the Annual Report of 2025	AQ

Ortivus AB Stock

Stocks

ORTI B

SE0000123085

Advanced Medical Equipment & Technology

Valuation: Ortivus AB

Chart: Ortivus AB

Latest news : Ortivus AB

Press Releases: Ortivus AB

Quotes and Performance

Course Extremes

Managers and Directors: Ortivus AB

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	+2.27%
1 month	-0.28%
3 months	+22.03%
6 months	+48.76%
Current year	+48.15%

1 week	1.64	2
1 month	1.4	2
Current year	1.14	2.14
1 year	0.8	2.14
3 years	0.8	4.99
5 years	0.8	7.74
10 years	0.8	8.9

Manager	Title	Age	Since
Gustaf Nordenhök CEO	Chief Executive Officer	-	01/01/2024
Minni Raij DFI	Director of Finance/CFO	-	16/02/2026
Gabriel Åhbeck CTO	Chief Tech/Sci/R&D Officer	55	01/01/2013

Director	Title	Age	Since
Peter Edwall BRD	Director/Board Member	71	01/01/2008
Anna Klevby Dalgaard BRD	Director/Board Member	47	01/01/2017
Jarnberg Ulf BRD	Director/Board Member	62	01/01/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ORTIVUS AB	0.00%	+2.27%	+34.33%	-58.62%	17.06M
THERMO FISHER SCIENTIFIC, INC.	-1.33%	-0.73%	+16.53%	-10.78%	174B
INTUITIVE SURGICAL, INC.	-0.45%	-2.61%	-19.74%	+30.31%	146B
DANAHER CORPORATION	-0.38%	-2.28%	-10.25%	-25.35%	127B
BOSTON SCIENTIFIC CORPORATION	-0.55%	-3.38%	-52.97%	-8.31%	69.72B
EDWARDS LIFESCIENCES CORPORATION	-0.76%	-0.99%	+13.25%	-2.62%	49.01B
SIEMENS HEALTHINEERS AG	+0.67%	-0.60%	-24.14%	-34.78%	44.74B
AGILENT TECHNOLOGIES, INC.	+0.22%	-4.13%	+10.90%	+8.65%	36.67B
WATERS CORPORATION	-1.17%	-2.69%	+3.87%	+35.04%	34.91B
GE HEALTHCARE TECHNOLOGIES INC.	+1.04%	+0.79%	-9.79%	-16.21%	29.65B
Average	-0.27%	-1.66%	-3.80%	-8.27%	71.22B
Weighted average by Cap.	-0.55%	-1.98%	-7.27%	-2.67%

	2024	2025
Net sales	80.41M 8.52M 7.37M 6.79M 6.36M 11.94M 810M 12.11M 31.24M 395M 31.98M 31.3M 1.38B	73.4M 7.78M 6.73M 6.2M 5.81M 10.89M 740M 11.06M 28.52M 360M 29.19M 28.57M 1.26B
Net income	-24.9M -2.64M -2.28M -2.1M -1.97M -3.7M -251M -3.75M -9.68M -122M -9.9M -9.69M -426M	-21.88M -2.32M -2M -1.85M -1.73M -3.25M -220M -3.3M -8.5M -107M -8.7M -8.51M -375M
Net Debt	30.75M 3.26M 2.82M 2.6M 2.43M 4.56M 310M 4.63M 11.95M 151M 12.23M 11.97M 526M	10.64M 1.13M 975K 899K 842K 1.58M 107M 1.6M 4.13M 52.22M 4.23M 4.14M 182M